Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-002571
Accepted
2024-08-19 00:15:13
Documents
1
Effectiveness Date
2024-08-16
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 593
  Complete submission text file 9999999995-24-002571.txt   1877
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Filer) CIK: 0001840229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-281522 | Film No.: 241218147
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)